Axsome Therapeuticsincis A Biopharmaceutical Company Based In New Yorkfocused On Developing Innovative Therapies For Central Nervous Systemcnsconditionsfounded In January 2012The Company Aims To Address Unmet Medical Needs In Neurology Through Advanced Research And Technologyits Mission Is To Create Medicines That Significantly Enhance The Lives Of Patients With Cns Disorders The Company Has Developed Several Key Productsincluding Auvelity For Major Depressive Disordersunosi For Excessive Daytime Sleepiness And Obstructive Sleep Apneaand Symbravo For Acute Migraine Headachesaxsome S Pipeline Features Promising Candidates Targeting Various Conditions Such As Alzheimer S Disease Agitationsmoking Cessationand Attention Deficit Hyperactivity Disorderaxsome Therapeutics Collaborates With Leading Research Institutions To Expedite The Development Of Its Therapiesdemonstrating A Commitment To Innovation And Patient Carethe Company Operates In Multiple Countriesincluding The United Statescanadaaustraliairelandand Maltareflecting Its Global Reach In Serving Patients And Healthcare Providers
No conferences found for this company.
| Company Name | Axsome Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
